Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy

被引:7
|
作者
Tian, Hongwei
Yang, Chengzhi
Song, Yunhu
Wang, Hongyue
Yuan, Jiansong
Cui, Jingang
Liu, Shengwen
Hu, Fenghuan
Yang, Weixian
Jiang, Xiaowei
Qiao, Shubin [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, 167 North Lishi Rd, Beijing, Peoples R China
[2] Peking Union Med Coll, 167 North Lishi Rd, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Microvascular density; Myocardial fibrosis; Hypertrophic obstructive cardiomyopathy; HEART-FAILURE; TISSUE; DYSFUNCTION; DISARRAY; COLLAGEN; YOUNG;
D O I
10.1159/000493005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a myocardial disease characterized by fibrosis and microvascular ischemia. Microvessels play a critical role in myocardial fibrosis in HOCM. However, it remains unclear whether or not myocardial fibrosis is associated with microvascular density (MVD) changes. Objective: The aim of the present study was to investigate whether a reduction in MVD is related to myocardial fibrosis in HOCM cardiac samples. Methods: We analyzed MVD and fibrosis in myectomy left ventricular (LV) septal wall specimens from 53 HOCM patients. Control myocardium from the LV septal wall was collected at autopsy of 9 individuals who died of noncardiac causes. Results: The fibrosis ratio (% area) in HOCM was higher and the MVD was lower than that in control subjects (i.e., 12.7 +/- 10.0 vs. 4.0 +/- 1.4%, p = 0.012, and 480.9 +/- 206.7 vs. 1,425 +/- 221/mm(2), p < 0.001). Patients with mild fibrosis had a higher MVD than patients with moderate fibrosis (i.e., 568.2 +/- 214.8 vs. 403.2 +/- 167.8/mm(2), p = 0.006) and patients with severe fibrosis (i.e., 568.2 +/- 214.8 vs. 378.6 +/- 154.0/mm(2), p =0.024). Furthermore, a significant negative correlation was found between myocardial fibrosis and MVD in HOCM patients (r = -0.40, p = 0.003), which was also found in mild fibrosis (r = -0.40, p = 0.043), moderate fibrosis (r = -0.50, p = 0.024), and severe fibrosis (r = -0.24, p = 0.61), although no significant differences were observed in severe fibrosis. Additionally, we demonstrated that late gadolinium enhancement was negatively correlated with MVD (r = -0.37, p = 0.03) and positively correlated with fibrosis (r = 0.44, p = 0.01). Conclusion: HOCM patients had a higher myocardial fibrosis ratio and a lower MVD. The severity of myocardial fibrosis was negatively correlated with MVD in HOCM. These findings showed that a reduced MVD may contribute to myocardial fibrosis in HOCM. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:202 / 211
页数:10
相关论文
共 50 条
  • [1] Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy: A Histopathological Comparison of Pediatric and Adult Patients
    Zhang, MingKui
    Zhang, Zhengjie
    Xue, Hui
    Fan, Lixin
    Wen, Yan
    HEART SURGERY FORUM, 2022, 25 (01): : E42 - E47
  • [2] A CASE OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY WITH EXTENSIVE MYOCARDIAL FIBROSIS
    ANDO, J
    YASUDA, H
    SAKAMOTO, S
    KUDO, T
    HIRAMA, M
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1984, 48 (09): : 1054 - 1055
  • [3] Myocardial bridging in obstructive hypertrophic cardiomyopathy: a risk factor for myocardial fibrosis
    Changpeng Song
    Shengwei Wang
    Xinli Guo
    Manyun Huang
    Xinxin Zheng
    Jie Lu
    Keshan Ji
    Shihua Zhao
    Jingang Cui
    Shuiyun Wang
    Xiaohong Huang
    BMC Medicine, 22
  • [4] Myocardial bridging in obstructive hypertrophic cardiomyopathy: a risk factor for myocardial fibrosis
    Song, Changpeng
    Wang, Shengwei
    Guo, Xinli
    Huang, Manyun
    Zheng, Xinxin
    Lu, Jie
    Ji, Keshan
    Zhao, Shihua
    Cui, Jingang
    Wang, Shuiyun
    Huang, Xiaohong
    BMC MEDICINE, 2024, 22 (01)
  • [5] Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
    Almaas, Vibeke M.
    Haugaa, Kristina H.
    Strom, Erik H.
    Scott, Helge
    Smith, Hans-Jorgen
    Dahl, Christen P.
    Geiran, Odd R.
    Endresen, Knut
    Aakhus, Svend
    Amlie, Jan Peder
    Edvardsen, Thor
    HEART, 2014, 100 (08) : 631 - 638
  • [6] HISTOPATHOLOGICAL SPECIFICITY OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - MYOCARDIAL FIBER DISARRAY AND MYOCARDIAL FIBROSIS
    STJOHNSUTTON, MG
    LIE, JT
    ANDERSON, KR
    OBRIEN, PC
    FRYE, RL
    BRITISH HEART JOURNAL, 1980, 44 (04): : 433 - 443
  • [7] Systemic inflammation is associated with myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
    Guo, Xinli
    Zhang, Jian
    Huang, Manyun
    Song, Changpeng
    Nie, Changrong
    Zheng, Xinxin
    Wang, Shuiyun
    Huang, Xiaohong
    ESC HEART FAILURE, 2025, 12 (01): : 582 - 591
  • [8] MYOCARDIAL BRIDGES IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    KITAZUME, H
    KRAMER, JR
    KRAUTHAMER, D
    ELTOBGI, S
    PROUDFIT, WL
    SONES, FM
    AMERICAN HEART JOURNAL, 1983, 106 (01) : 131 - 135
  • [9] Hypertrophic obstructive cardiomyopathy complicated with acute myocardial infarction and diffuse fibrosis: surgery or not?
    Wang, Yunhong
    Zhao, Xuemei
    Zhai, Mei
    Huang, Yan
    Zhou, Qiong
    Zhang, Yuhui
    Mao, Yi
    Zhang, Jian
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [10] SPECIFICITY AND TOPOGRAPHY OF MYOCARDIAL FIBER DISARRAY AND FIBROSIS IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM)
    SUTTON, MS
    ANDERSON, KR
    LIE, JT
    FRYE, RL
    CIRCULATION, 1977, 56 (04) : 205 - 205